# China NMPA Product Recall - Electric anti-bedsore air mattress

Source: https://www.globalkeysolutions.net/records/china_product_recall/chongqing-huabo-military-health-pharmaceutical-co-ltd/c95b7c03-03d7-4678-b6c7-f33fc2b1ebf3/
Source feed: China

> China NMPA product recall for Electric anti-bedsore air mattress by Chongqing Huabo Military Health Pharmaceutical Co., Ltd. published December 02, 2019. Recall level: Level 3. Chongqing Huabo Junwei Pharmaceutical Co., Ltd. initiated a voluntary Level III recall of its Electr

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Chongqing Huabo Junwei Pharmaceutical Co., Ltd. voluntarily recalls electric anti-decubitus air mattresses.
- Company Name: Chongqing Huabo Military Health Pharmaceutical Co., Ltd.
- Publication Date: 2019-12-02
- Product Name: Electric anti-bedsore air mattress
- Recall Level: Level 3
- Recall Reason: The "weight unit Kg symbol" on the controller display screen does not conform to the International System of Units (SI) of GB3100 and the supplementary unit requirements of GB9706.1-2007, among other reasons.
- Discovering Company: Chongqing Huabo Military Health Pharmaceutical Co., Ltd.
- Manufacturing Company: Chongqing Huabo Military Health Pharmaceutical Co., Ltd.
- Summary: Chongqing Huabo Junwei Pharmaceutical Co., Ltd. initiated a voluntary Level III recall of its Electric Anti-Decubitus Air Mattress (registration number: Yu 20182560057) following a Chongqing Municipal Supervision and Inspection on May 15, 2019. The primary issue identified was that the controller display on specific units, such as JWM85017061007, showed the unit "kg" (kilogram), which deviates from the International System of Units (SI) requirements stipulated in GB3100 and the supplementary unit requirements of GB9706.1-2007. Under the guidance of the National Medical Products Administration (NMPA) framework, the company's corrective actions include a multi-step process. The sales department is tasked with tracing and quantifying affected products. Subsequently, the quality control department will develop a comprehensive "Recall Investigation and Evaluation Plan" and a "Recall Implementation Plan," detailing the scope, methodology, timeline, communication strategy, and post-recall measures. The management representative is responsible for submitting all pertinent recall documentation, including the "Medical Device Recall Event Report Form," to the State Drug Administration for official record-keeping. Finally, the sales department will issue formal recall notices to customers, with the quality management department overseeing the implementation and verifying the efficacy of these communications. The recall report was dated November 6, 2019, with the public announcement on December 2, 2019.

Company: https://www.globalkeysolutions.net/companies/chongqing-huabo-military-health-pharmaceutical-co-ltd/602caf0c-6e71-456b-bf99-ac5350ae35c0/